Zocor (simvastatin) coated tablets 20 mg. №28

$28.50

Manufacturer: Switzerland

Purpose: Inhibits cholesterol production to lower LDL levels in the blood.

Out of stock

SKU: MED61983 Category:

Description

Zocor (Simvastatin) Coated Tablets 20 mg. №28

Ingredients:

  • Each coated tablet contains 20 mg of simvastatin as the active ingredient.
  • Other ingredients include lactose monohydrate, microcrystalline cellulose, pregelatinized starch, and more.

Dosage:

The recommended dosage is one 20 mg coated tablet per day. It is important to follow the instructions provided by your healthcare provider.

Indications:

Zocor (simvastatin) is indicated for the treatment of high cholesterol and triglyceride levels. It is used in conjunction with a healthy diet and lifestyle changes.

Contraindications:

Do not take Zocor if you are pregnant, breastfeeding, or have active liver disease. It is important to inform your doctor about any existing medical conditions or medications before starting Zocor.

Directions:

Swallow the tablet whole with a glass of water, with or without food. Do not crush or chew the tablet. Follow your doctor’s instructions carefully.

Scientific Evidence:

Studies have shown that simvastatin effectively reduces LDL cholesterol levels and lowers the risk of cardiovascular events. Research published in the New England Journal of Medicine demonstrated the benefits of statins in preventing heart disease.

Additional Information:

  • It is important to have regular monitoring of liver function tests while taking Zocor.
  • Inform your healthcare provider of any unusual symptoms or side effects.

Pharmacological Effects: Simvastatin works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis. By lowering cholesterol levels, it reduces the risk of atherosclerosis and cardiovascular events.

Clinical Trials: Clinical trials have shown that Zocor is effective in reducing LDL cholesterol and improving overall lipid profiles. A study published in the Journal of the American Medical Association demonstrated the efficacy of simvastatin in reducing the incidence of coronary events.